Zim Laboratories Limited (ZIMLAB) - Total Liabilities

Latest as of September 2025: Rs2.19 Billion INR ≈ $23.66 Million USD

Based on the latest financial reports, Zim Laboratories Limited (ZIMLAB) has total liabilities worth Rs2.19 Billion INR (≈ $23.66 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ZIMLAB cash generation efficiency to assess how effectively this company generates cash.

Zim Laboratories Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Zim Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. Check ZIMLAB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Zim Laboratories Limited Competitors by Total Liabilities

The table below lists competitors of Zim Laboratories Limited ranked by their total liabilities.

Company Country Total Liabilities
Xplus SA
WAR:XPL
Poland zł19.44 Million
Tolins Tyres Ltd
NSE:TOLINS
India Rs468.00 Million
Molinos Juan Semino SA
BA:SEMI
Argentina AR$13.45 Billion
Magnitude International Ltd Ordinary Shares
NASDAQ:MAGH
USA $7.91 Million
Sequana Medical NV
BR:SEQUA
Belgium €53.74 Million
Yuasa Battery (Thailand) Public Company Limited
BK:YUASA
Thailand ฿590.10 Million
Davolink Inc.
KQ:340360
Korea ₩31.74 Billion
2S Metal Public Company Limited
BK:2S
Thailand ฿342.86 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Zim Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zim Laboratories Limited (ZIMLAB) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zim Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zim Laboratories Limited (2013–2025)

The table below shows the annual total liabilities of Zim Laboratories Limited from 2013 to 2025.

Year Total Liabilities Change
2025-03-31 Rs2.20 Billion
≈ $23.77 Million
+5.63%
2024-03-31 Rs2.08 Billion
≈ $22.50 Million
+47.33%
2023-03-31 Rs1.41 Billion
≈ $15.27 Million
-14.88%
2022-03-31 Rs1.66 Billion
≈ $17.94 Million
+1.15%
2021-03-31 Rs1.64 Billion
≈ $17.74 Million
-4.34%
2020-03-31 Rs1.71 Billion
≈ $18.55 Million
-3.30%
2019-03-31 Rs1.77 Billion
≈ $19.18 Million
+9.68%
2018-03-31 Rs1.62 Billion
≈ $17.49 Million
+14.89%
2017-03-31 Rs1.41 Billion
≈ $15.22 Million
-10.83%
2016-03-31 Rs1.58 Billion
≈ $17.07 Million
-7.66%
2015-03-31 Rs1.71 Billion
≈ $18.48 Million
+15.82%
2014-03-31 Rs1.48 Billion
≈ $15.96 Million
+32.34%
2013-03-31 Rs1.11 Billion
≈ $12.06 Million
--

About Zim Laboratories Limited

NSE:ZIMLAB India Drug Manufacturers - Specialty & Generic
Market Cap
$46.35 Million
Rs4.29 Billion INR
Market Cap Rank
#22166 Global
#1225 in India
Share Price
Rs87.94
Change (1 day)
+3.05%
52-Week Range
Rs60.26 - Rs120.82
All Time High
Rs149.00
About

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers the… Read more